Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.66 USD | +1.00% | -4.16% | +13.44% |
05-13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
05-10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.44% | 1.66B | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.23% | 22.28B | |
-5.66% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Oppenheimer Adjusts Soleno Therapeutics Price Target to $2 From $3, Maintains Outperform Rating